. . . . . . . "Arteri\u00E1ln\u00ED hypertenze\nObvykl\u00E1 d\u00E1vka je 20 mg jednou denn\u011B.\nStabiln\u00ED n\u00E1mahov\u00E1 ang\u00EDna pectoris\nObvykl\u00E1 d\u00E1vka je jedna tableta (20 mg) jednou denn\u011B. U n\u011Bkter\u00FDch pacient\u016F (nap\u0159. u pacient\u016F s\u00A0chronickou obstruk\u010Dn\u00ED plicn\u00ED chorobou) je vhodn\u00E9 za\u010D\u00EDt l\u00E9\u010Dbu ni\u017E\u0161\u00ED d\u00E1vkou 10 mg/den. V\u00A0n\u011Bkter\u00FDch p\u0159\u00EDpadech je nutno zv\u00FD\u0161it denn\u00ED d\u00E1vku a\u017E na 40 mg.\nPod\u00E1n\u00ED a slo\u017Een\u00ED potravy neovliv\u0148uje biologickou dostupnost betaxololu. Kalend\u00E1\u0159n\u00ED balen\u00ED zlep\u0161uje spolupr\u00E1ci pacienta omezen\u00EDm rizika, \u017Ee si pacient zapomene vz\u00EDt l\u00E9k. P\u0159\u00EDpravek se u\u017E\u00EDv\u00E1 v\u017Edy ve stejnou denn\u00ED dobu, nejl\u00E9pe r\u00E1no.\nD\u00E1vkov\u00E1n\u00ED u pacient\u016F s jatern\u00EDm nebo ledvinn\u00FDm selh\u00E1n\u00EDm:\nU pacient\u016F s ledvinn\u00FDm selh\u00E1n\u00EDm (kreatininov\u00E1 clearance do 20 ml/min.) nen\u00ED t\u0159eba upravovat denn\u00ED d\u00E1vku, ale doporu\u010Duje se klinick\u00E9 sledov\u00E1n\u00ED na za\u010D\u00E1tku l\u00E9\u010Dby, dokud nen\u00ED dosa\u017Eeno vyrovnan\u00FDch plasmatick\u00FDch hladin l\u00E9ku (v pr\u016Fm\u011Bru za 4 dny).\nU pacient\u016F v dialyza\u010Dn\u00EDm programu (hemodial\u00FDza nebo peritone\u00E1ln\u00ED dial\u00FDza) je doporu\u010Den\u00E1 denn\u00ED d\u00E1vka na za\u010D\u00E1tku l\u00E9\u010Dby 10 mg/den bez ohledu na frekvenci a dobu dial\u00FDzy.\nU pacient\u016F s jatern\u00EDm selh\u00E1n\u00EDm nen\u00ED t\u0159eba upravovat d\u00E1vku. Doporu\u010Duje se pe\u010Dliv\u00E9 klinick\u00E9 sledov\u00E1n\u00ED na za\u010D\u00E1tku l\u00E9\u010Dby.\n"@cs . "004.002" . "4.2. D\u00E1vkov\u00E1n\u00ED a zp\u016Fsob pod\u00E1n\u00ED"@cs . .